The International Association for the Study of Lung Cancer
The IASLC is a global multidisciplinary organization dedicated to eradication of all forms of lung cancer. From provision of educational events around the world and virtually to research projects and publications that advance the science of lung cancer, the IASLC's members—consisting of medical, surgical, and radiation oncologists, as well as other thoracic oncology specialists such as nurses, basic scientists, pathologists, radiologists, pulmonologists, statisticians, patient research advocates, patients, and their caregivers—are raising the bar for care of patients with lung cancer.
New Forum to Discuss Molecular Challenges
When the initial molecular report suggested a ROS1 rearrangement, crizotinib was started in expectation of a typically great response. However, when the first on-treatment scan showed an increase in the size of the lung cancer it became obvious that this case was far from typical. Moderated by Dr. D. Ross Camidge, who provided a remote second opinion on the case, the patient, Mr. Bill Brand, and his primary oncologist, Dr. Ron Natale, discuss the twists and turns in the diagnosis and provide crucial insights on the nuances of understanding molecular testing, the best way to use and not abuse remote second opinions, and how you can and should rapidly adapt a plan that isn’t working. Mr. Brand, who had to join one molecularly specific patient support group, leave and then join another different one, also provides advice for patients regarding self-advocacy and handling direct communication with physicians.
Journal of Thoracic Oncology & JTO Clinical and Research Reports
Lung and thoracic specialists count on the IASLC’s journals to provide perspective on innovation in prevention, detention, diagnosis and cutting-edge treatments. As a leading medical journal, JTO focuses on lung and thoracic cancers and is dedicated to presenting original research reviews and opinions from a wide range of disciplines within the medical community. JTO CRR, the official open access journal of the IASLC, complements the JTO by offering authors a gold open access publication option.